首页> 美国卫生研究院文献>BMC Pharmacology Toxicology >The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

【2h】

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

机译：氟马沙坦和瑞舒伐他汀联合治疗高血压和血脂异常的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundHypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia.

机译：背景高血压和血脂异常是心血管疾病（CVD）事件的主要危险因素。这项研究的目的是评估氟马沙坦与瑞舒伐他汀共同治疗高血压和高胆固醇血症患者的疗效和安全性。

著录项

期刊名称 BMC Pharmacology Toxicology
作者
Moo-Yong Rhee; Taehoon Ahn; Kiyuk Chang; Shung Chull Chae; Tae-Hyun Yang; Wan Joo Shim; Tae Soo Kang; Jae-Kean Ryu; Deuk-Young Nah; Tae-Ho Park; In-Ho Chae; Seung Woo Park; Hae-Young Lee; Seung-Jea Tahk; Young Won Yoon; Chi Young Shim; Dong-Gu Shin; Hong Seog Seo; Sung Yun Lee; Doo Il Kim; Jun Kwan; Seung-Jae Joo; Myung Ho Jeong; Jin-Ok Jeong; Ki Chul Sung; Seok Yeon Kim; Sang-Hyun Kim; Kook-Jin Chun; Dong Joo Oh;
展开▼
作者单位

展开▼
年(卷),期 2017(18),-1
年度 2017
页码 2
总页数 11
原文格式 PDF
正文语种
中图分类药学;
关键词
Fimasartan Rosuvastatin Hypertension Hypercholesterolemia;

机译：Fimasartan;瑞舒伐他汀;高血压;高胆固醇血症;

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial [J] . Hong Soon Jun, Jeong Han Saem, Cho Jin-Man, Clinical therapeutics . 2019,第2期

机译：三重疗法与筛选，氨氯堇和罗萨伐他汀在血脂血症和高血压患者中的疗效和安全性：Jeil Telmisartan，氨氯堇和罗萨伐他汀随机临床试验
2. Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study [J] . Oh Gyu Chul, Han Jung-Kyu, Han Ki Hoon, Clinical therapeutics . 2018,第5期

机译：固定剂量组合治疗与韩国高血压和血脂血症患者综合剂量组合治疗的疗效和安全性：Telsta-yu（来自玉汉的Telmisartan-Rosuvastatin），多中心，随机，4臂，双盲，安慰剂控制，阶段 III研究
3. Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) [J] . Jin-Sun Park, Joon-Han Shin, Taek-Jong Hong, Drug Design, Development and Therapy . 2016,第5期

机译：olmesartan medoxomil和rosuvastatin固定剂量联合治疗对韩国轻度至中度高血压和血脂异常患者的疗效和安全性：一项为期8周，多中心，随机，双盲，析因设计的研究（OLSTA-D RCT：OLmesartan rosuvaSTAtin （大雄）
4. Using Therapeutic Circles to Visualize Guideline-Based Therapeutic Recommendations for Patients with Multiple Chronic Conditions: A Case Study with GO-DSS on Hypertension, Type 2 Diabetes, and Dyslipidemia [C] . Brigitte Seroussi, Alexra Galopin, Mouhssin Gaouar, MEDINFO . 2017

机译：使用治疗圆来可视化基于指南的治疗性建议，为多种慢性条件的患者进行：一种案例研究高血压的DSS，2型糖尿病和血脂血症
5. Assessment of the relationship between acanthosis nigricans (AN) and hyperglycemia, hypertension and dyslipidemia among children and adolescents of Hawaiian ethnicity. [D] . Robbins, Karen. 2007

机译：评估黑棘皮病（AN）与夏威夷族儿童和青少年的高血糖，高血压和血脂异常之间的关系。
6. Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week multicenter randomized double-blind factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) [O] . Jin-Sun Park, Joon-Han Shin, Taek-Jong Hong, 2016

机译：olmesartan medoxomil和rosuvastatin固定剂量联合治疗对韩国轻至中度高血压和血脂异常患者的疗效和安全性：一项为期8周多中心随机双盲析因设计的研究（OLSTA-D RCT：OLmesartan rosuvaSTAtin （大雄）
7. The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia [O] . 2017

机译：氟马沙坦和瑞舒伐他汀联合治疗高血压和血脂异常的疗效和安全性

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

摘要

著录项

相似文献

相关主题

期刊订阅